
Keywords: آپو; AD; Alzheimer's disease; ADNI; Alzheimer's disease neuroimaging initiative; APOE; apolipoprotein E; CDR; clinical dementia rating; DWMH; deep white matter hyperintensity; FLAIR; fluid attenuated inversion recovery; MCI; mild cognitive impairment; MMSE; mi